Dixon Hubard Feinour & Brown Inc Medtronic PLC Transaction History

Dixon Hubard Feinour & Brown Inc

$842 Million
Q2 2022

A detailed history of Dixon Hubard Feinour & Brown Inc transactions in Medtronic PLC stock. As of the latest transaction made, Dixon Hubard Feinour & Brown Inc holds 13,181 shares of MDT stock, worth $1.29 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

13,181

Previous 13,169 0.09%

Holding current value

$1.29 Million

Previous $1.46 Million 19.03%

% of portfolio

0.14%

Previous 0.15%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$87.4 - $113.09 $1,048 - $1,357	12 Added 0.09%	13,181 $1.18 Million
Q1 2022 May 09, 2022	SELL	$100.58 - $112.38 $29,771 - $33,264	-296 Reduced 2.2%	13,169 $1.46 Million
Q4 2021 Jan 10, 2022	BUY	$99.53 - $127.75 $1.17 Million - $1.5 Million	11,710 Added 667.24%	13,465 $1.39 Million
Q2 2021 Aug 23, 2021	SELL	$118.19 - $131.5 $300,557 - $334,404	-2,543 Reduced 59.17%	1,755 $218,000
Q3 2020 Nov 12, 2020	SELL	$90.13 - $108.78 $3,605 - $4,351	-40 Reduced 0.92%	4,298 $447,000
Q2 2020 Jul 31, 2020	SELL	$84.11 - $103.33 $74,353 - $91,343	-884 Reduced 16.93%	4,338 $418,000
Q1 2020 May 15, 2020	BUY	$72.92 - $121.3 $45,939 - $76,419	630 Added 13.72%	5,222 $471,000
Q4 2019 Feb 14, 2020	BUY	$104.49 - $114.54 $20,375 - $22,335	195 Added 4.43%	4,592 $521,000
Q3 2019 Nov 13, 2019	BUY	$98.02 - $111.18 $134,777 - $152,872	1,375 Added 45.5%	4,397 $478,000
Q1 2019 May 17, 2019	BUY	$82.45 - $93.79 $1,813 - $2,063	22 Added 0.73%	3,022 $275,000
Q4 2017 Feb 20, 2018	BUY	$76.93 - $83.5 $230,790 - $250,500	3,000	3,000 $242,000

Others Institutions Holding MDT

# of Institutions

2,455

Shares Held

1.07B

Call Options Held

10.9M

Put Options Held

9.19M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $130B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.

Account

Dixon Hubard Feinour & Brown Inc Medtronic PLC Transaction History